Ontology type: schema:Chapter
2017-07-15
AUTHORSVito Piazza , A. Montalto , C. Amarelli , A. Loforte , Francesco Musumeci
ABSTRACTHeart failure is a clinical syndrome with different etiologies and quite variable presentation. The acute onset can be due to exacerbation of signs and symptoms of known HF (acute decompensated heart failure) or to the sudden appearance of HF in a patient with previous normal cardiac function (new-onset or de novo HF), as it happens after myocardial infarction or myocarditis. In chronic HF symptoms of ventricular dysfunction occur in a time span of weeks or months, generally caused by long-lasting ischemic heart disease, dilated cardiomyopathies, and hypertensive and valvular disease. With the advent of echocardiography, HF has been classified into two major subclasses: (1) heart failure with reduced ejection fraction (HFrEF), also called systolic heart failure, and (2) heart failure with preserved ejection fraction (HFpEF), also known as diastolic heart failure. The prevalence of heart failure increases rapidly with age. The Framingham Heart Study showed a prevalence of 8/1000 and up to 66/100 in 50–59 and 80–89 aged men, respectively [1]. In women, the prevalence of cardiac insufficiency was 8/1000 for the age group of 50–59 years and 7/1000 for age between 80 and 89 years. The incidence has similar trends, doubling for each subsequent decade of life. There are several reasons for this increase: the aging of the population, the improved efficacy of treatment of acute coronary syndromes with prolonged life span expectancy, and the significant increase of diabetes and obesity. As consequence the hospitalizations are progressively raising, due not only to the occurrence of worsening symptoms but also to comorbidities such as renal failure, electrolyte abnormalities, and multiorgan dysfunction. Risk factors for heart failure are age, sex, hypertension, diabetes, obesity, coronary artery disease, insulin resistance, genetic factors, and use of cardiotoxic drugs. In the SOLVD registry, 70% of patients suffering from heart failure had coronary heart disease and 7% hypertensive disease [2]. More... »
PAGES13-23
Mechanical Circulatory Support in End-Stage Heart Failure
ISBN
978-3-319-43381-3
978-3-319-43383-7
http://scigraph.springernature.com/pub.10.1007/978-3-319-43383-7_2
DOIhttp://dx.doi.org/10.1007/978-3-319-43383-7_2
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1090680142
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Cardiorespiratory Medicine and Haematology",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Division of Cardiology, Department of Cardiac Surgery and Heart Transplantation, San Camillo Hospital, Circonvallazione Gianicolense 87, 00152, Rome, Italy",
"id": "http://www.grid.ac/institutes/grid.416308.8",
"name": [
"Division of Cardiology, Department of Cardiac Surgery and Heart Transplantation, San Camillo Hospital, Circonvallazione Gianicolense 87, 00152, Rome, Italy"
],
"type": "Organization"
},
"familyName": "Piazza",
"givenName": "Vito",
"id": "sg:person.016116527146.47",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016116527146.47"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiac Surgery and Heart Transplantation, San Camillo Hospital, Rome, Italy",
"id": "http://www.grid.ac/institutes/grid.416308.8",
"name": [
"Department of Cardiac Surgery and Heart Transplantation, San Camillo Hospital, Rome, Italy"
],
"type": "Organization"
},
"familyName": "Montalto",
"givenName": "A.",
"id": "sg:person.01051341226.47",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051341226.47"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiovascular Surgery and Transplants Monaldi, Azienda dei Colli, Neaples, Italy",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Cardiovascular Surgery and Transplants Monaldi, Azienda dei Colli, Neaples, Italy"
],
"type": "Organization"
},
"familyName": "Amarelli",
"givenName": "C.",
"id": "sg:person.01246247247.72",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246247247.72"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiovascular Surgery and Transplantation, S. Orsola-Malpighi Hospital, Bologna University, Bologna, Italy",
"id": "http://www.grid.ac/institutes/grid.412311.4",
"name": [
"Department of Cardiovascular Surgery and Transplantation, S. Orsola-Malpighi Hospital, Bologna University, Bologna, Italy"
],
"type": "Organization"
},
"familyName": "Loforte",
"givenName": "A.",
"id": "sg:person.0735112626.95",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735112626.95"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Director of Cardiovascular Medicine, Director of Cardiac Surgery and Transplantation, San Camillo-Forlanini Hospital, Rome, Italy",
"id": "http://www.grid.ac/institutes/grid.416308.8",
"name": [
"Director of Cardiovascular Medicine, Director of Cardiac Surgery and Transplantation, San Camillo-Forlanini Hospital, Rome, Italy"
],
"type": "Organization"
},
"familyName": "Musumeci",
"givenName": "Francesco",
"id": "sg:person.01117454426.66",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117454426.66"
],
"type": "Person"
}
],
"datePublished": "2017-07-15",
"datePublishedReg": "2017-07-15",
"description": "Heart failure is a clinical syndrome with different etiologies and quite variable presentation. The acute onset can be due to exacerbation of signs and symptoms of known HF (acute decompensated heart failure) or to the sudden appearance of HF in a patient with previous normal cardiac function (new-onset or de novo HF), as it happens after myocardial infarction or myocarditis. In chronic HF symptoms of ventricular dysfunction occur in a time span of weeks or months, generally caused by long-lasting ischemic heart disease, dilated cardiomyopathies, and hypertensive and valvular disease. With the advent of echocardiography, HF has been classified into two major subclasses: (1) heart failure with reduced ejection fraction (HFrEF), also called systolic heart failure, and (2) heart failure with preserved ejection fraction (HFpEF), also known as diastolic heart failure. The prevalence of heart failure increases rapidly with age. The Framingham Heart Study showed a prevalence of 8/1000 and up to 66/100 in 50\u201359 and 80\u201389 aged men, respectively [1]. In women, the prevalence of cardiac insufficiency was 8/1000 for the age group of 50\u201359 years and 7/1000 for age between 80 and 89 years. The incidence has similar trends, doubling for each subsequent decade of life. There are several reasons for this increase: the aging of the population, the improved efficacy of treatment of acute coronary syndromes with prolonged life span expectancy, and the significant increase of diabetes and obesity. As consequence the hospitalizations are progressively raising, due not only to the occurrence of worsening symptoms but also to comorbidities such as renal failure, electrolyte abnormalities, and multiorgan dysfunction. Risk factors for heart failure are age, sex, hypertension, diabetes, obesity, coronary artery disease, insulin resistance, genetic factors, and use of cardiotoxic drugs. In the SOLVD registry, 70% of patients suffering from heart failure had coronary heart disease and 7% hypertensive disease [2].",
"editor": [
{
"familyName": "Montalto",
"givenName": "Andrea",
"type": "Person"
},
{
"familyName": "Loforte",
"givenName": "Antonio",
"type": "Person"
},
{
"familyName": "Musumeci",
"givenName": "Francesco",
"type": "Person"
},
{
"familyName": "Krabatsch",
"givenName": "Thomas",
"type": "Person"
},
{
"familyName": "Slaughter",
"givenName": "Mark S.",
"type": "Person"
}
],
"genre": "chapter",
"id": "sg:pub.10.1007/978-3-319-43383-7_2",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": {
"isbn": [
"978-3-319-43381-3",
"978-3-319-43383-7"
],
"name": "Mechanical Circulatory Support in End-Stage Heart Failure",
"type": "Book"
},
"keywords": [
"heart failure",
"ejection fraction",
"heart disease",
"advent of echocardiography",
"end-stage CHF",
"reduced ejection fraction",
"systolic heart failure",
"diastolic heart failure",
"acute coronary syndrome",
"coronary artery disease",
"ischemic heart disease",
"coronary heart disease",
"normal cardiac function",
"exacerbation of signs",
"Framingham Heart Study",
"ventricular dysfunction",
"acute onset",
"HF symptoms",
"coronary syndrome",
"electrolyte abnormalities",
"multiorgan dysfunction",
"renal failure",
"artery disease",
"hypertensive disease",
"valvular disease",
"cardiac insufficiency",
"insulin resistance",
"clinical syndrome",
"myocardial infarction",
"risk factors",
"different etiologies",
"cardiac function",
"variable presentation",
"cardiotoxic drugs",
"life span expectancy",
"aged men",
"Heart Study",
"age groups",
"improved efficacy",
"disease",
"symptoms",
"prevalence",
"genetic factors",
"obesity",
"patients",
"significant increase",
"diabetes",
"dysfunction",
"syndrome",
"age",
"major subclasses",
"failure",
"myocarditis",
"hypertension",
"exacerbation",
"hospitalization",
"comorbidities",
"echocardiography",
"infarction",
"cardiomyopathy",
"registry",
"etiology",
"insufficiency",
"physiopathology",
"years",
"abnormalities",
"incidence",
"weeks",
"months",
"women",
"drugs",
"efficacy",
"men",
"sex",
"treatment",
"factors",
"onset",
"similar trend",
"presentation",
"signs",
"sudden appearance",
"increase",
"expectancy",
"CHF",
"group",
"population",
"MCS",
"aging",
"subsequent decades",
"study",
"life",
"appearance",
"fraction",
"occurrence",
"HF",
"resistance",
"subclasses",
"use",
"function",
"advent",
"consequences",
"reasons",
"time span",
"decades",
"trends",
"fate",
"span",
"era"
],
"name": "Physiopathology and Fate of End-Stage CHF in the Era of MCS",
"pagination": "13-23",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1090680142"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/978-3-319-43383-7_2"
]
}
],
"publisher": {
"name": "Springer Nature",
"type": "Organisation"
},
"sameAs": [
"https://doi.org/10.1007/978-3-319-43383-7_2",
"https://app.dimensions.ai/details/publication/pub.1090680142"
],
"sdDataset": "chapters",
"sdDatePublished": "2022-05-20T07:45",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/chapter/chapter_317.jsonl",
"type": "Chapter",
"url": "https://doi.org/10.1007/978-3-319-43383-7_2"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-43383-7_2'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-43383-7_2'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-43383-7_2'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-319-43383-7_2'
This table displays all metadata directly associated to this object as RDF triples.
230 TRIPLES
23 PREDICATES
134 URIs
126 LITERALS
7 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/978-3-319-43383-7_2 | schema:about | anzsrc-for:11 |
2 | ″ | ″ | anzsrc-for:1102 |
3 | ″ | ″ | anzsrc-for:1103 |
4 | ″ | schema:author | N7adb950440e142508c9f64529e821022 |
5 | ″ | schema:datePublished | 2017-07-15 |
6 | ″ | schema:datePublishedReg | 2017-07-15 |
7 | ″ | schema:description | Heart failure is a clinical syndrome with different etiologies and quite variable presentation. The acute onset can be due to exacerbation of signs and symptoms of known HF (acute decompensated heart failure) or to the sudden appearance of HF in a patient with previous normal cardiac function (new-onset or de novo HF), as it happens after myocardial infarction or myocarditis. In chronic HF symptoms of ventricular dysfunction occur in a time span of weeks or months, generally caused by long-lasting ischemic heart disease, dilated cardiomyopathies, and hypertensive and valvular disease. With the advent of echocardiography, HF has been classified into two major subclasses: (1) heart failure with reduced ejection fraction (HFrEF), also called systolic heart failure, and (2) heart failure with preserved ejection fraction (HFpEF), also known as diastolic heart failure. The prevalence of heart failure increases rapidly with age. The Framingham Heart Study showed a prevalence of 8/1000 and up to 66/100 in 50–59 and 80–89 aged men, respectively [1]. In women, the prevalence of cardiac insufficiency was 8/1000 for the age group of 50–59 years and 7/1000 for age between 80 and 89 years. The incidence has similar trends, doubling for each subsequent decade of life. There are several reasons for this increase: the aging of the population, the improved efficacy of treatment of acute coronary syndromes with prolonged life span expectancy, and the significant increase of diabetes and obesity. As consequence the hospitalizations are progressively raising, due not only to the occurrence of worsening symptoms but also to comorbidities such as renal failure, electrolyte abnormalities, and multiorgan dysfunction. Risk factors for heart failure are age, sex, hypertension, diabetes, obesity, coronary artery disease, insulin resistance, genetic factors, and use of cardiotoxic drugs. In the SOLVD registry, 70% of patients suffering from heart failure had coronary heart disease and 7% hypertensive disease [2]. |
8 | ″ | schema:editor | N807fd67e22be4f43af92d5824b1858e3 |
9 | ″ | schema:genre | chapter |
10 | ″ | schema:inLanguage | en |
11 | ″ | schema:isAccessibleForFree | false |
12 | ″ | schema:isPartOf | Na2778b09f82a45268e1a06284a8066d7 |
13 | ″ | schema:keywords | CHF |
14 | ″ | ″ | Framingham Heart Study |
15 | ″ | ″ | HF |
16 | ″ | ″ | HF symptoms |
17 | ″ | ″ | Heart Study |
18 | ″ | ″ | MCS |
19 | ″ | ″ | abnormalities |
20 | ″ | ″ | acute coronary syndrome |
21 | ″ | ″ | acute onset |
22 | ″ | ″ | advent |
23 | ″ | ″ | advent of echocardiography |
24 | ″ | ″ | age |
25 | ″ | ″ | age groups |
26 | ″ | ″ | aged men |
27 | ″ | ″ | aging |
28 | ″ | ″ | appearance |
29 | ″ | ″ | artery disease |
30 | ″ | ″ | cardiac function |
31 | ″ | ″ | cardiac insufficiency |
32 | ″ | ″ | cardiomyopathy |
33 | ″ | ″ | cardiotoxic drugs |
34 | ″ | ″ | clinical syndrome |
35 | ″ | ″ | comorbidities |
36 | ″ | ″ | consequences |
37 | ″ | ″ | coronary artery disease |
38 | ″ | ″ | coronary heart disease |
39 | ″ | ″ | coronary syndrome |
40 | ″ | ″ | decades |
41 | ″ | ″ | diabetes |
42 | ″ | ″ | diastolic heart failure |
43 | ″ | ″ | different etiologies |
44 | ″ | ″ | disease |
45 | ″ | ″ | drugs |
46 | ″ | ″ | dysfunction |
47 | ″ | ″ | echocardiography |
48 | ″ | ″ | efficacy |
49 | ″ | ″ | ejection fraction |
50 | ″ | ″ | electrolyte abnormalities |
51 | ″ | ″ | end-stage CHF |
52 | ″ | ″ | era |
53 | ″ | ″ | etiology |
54 | ″ | ″ | exacerbation |
55 | ″ | ″ | exacerbation of signs |
56 | ″ | ″ | expectancy |
57 | ″ | ″ | factors |
58 | ″ | ″ | failure |
59 | ″ | ″ | fate |
60 | ″ | ″ | fraction |
61 | ″ | ″ | function |
62 | ″ | ″ | genetic factors |
63 | ″ | ″ | group |
64 | ″ | ″ | heart disease |
65 | ″ | ″ | heart failure |
66 | ″ | ″ | hospitalization |
67 | ″ | ″ | hypertension |
68 | ″ | ″ | hypertensive disease |
69 | ″ | ″ | improved efficacy |
70 | ″ | ″ | incidence |
71 | ″ | ″ | increase |
72 | ″ | ″ | infarction |
73 | ″ | ″ | insufficiency |
74 | ″ | ″ | insulin resistance |
75 | ″ | ″ | ischemic heart disease |
76 | ″ | ″ | life |
77 | ″ | ″ | life span expectancy |
78 | ″ | ″ | major subclasses |
79 | ″ | ″ | men |
80 | ″ | ″ | months |
81 | ″ | ″ | multiorgan dysfunction |
82 | ″ | ″ | myocardial infarction |
83 | ″ | ″ | myocarditis |
84 | ″ | ″ | normal cardiac function |
85 | ″ | ″ | obesity |
86 | ″ | ″ | occurrence |
87 | ″ | ″ | onset |
88 | ″ | ″ | patients |
89 | ″ | ″ | physiopathology |
90 | ″ | ″ | population |
91 | ″ | ″ | presentation |
92 | ″ | ″ | prevalence |
93 | ″ | ″ | reasons |
94 | ″ | ″ | reduced ejection fraction |
95 | ″ | ″ | registry |
96 | ″ | ″ | renal failure |
97 | ″ | ″ | resistance |
98 | ″ | ″ | risk factors |
99 | ″ | ″ | sex |
100 | ″ | ″ | significant increase |
101 | ″ | ″ | signs |
102 | ″ | ″ | similar trend |
103 | ″ | ″ | span |
104 | ″ | ″ | study |
105 | ″ | ″ | subclasses |
106 | ″ | ″ | subsequent decades |
107 | ″ | ″ | sudden appearance |
108 | ″ | ″ | symptoms |
109 | ″ | ″ | syndrome |
110 | ″ | ″ | systolic heart failure |
111 | ″ | ″ | time span |
112 | ″ | ″ | treatment |
113 | ″ | ″ | trends |
114 | ″ | ″ | use |
115 | ″ | ″ | valvular disease |
116 | ″ | ″ | variable presentation |
117 | ″ | ″ | ventricular dysfunction |
118 | ″ | ″ | weeks |
119 | ″ | ″ | women |
120 | ″ | ″ | years |
121 | ″ | schema:name | Physiopathology and Fate of End-Stage CHF in the Era of MCS |
122 | ″ | schema:pagination | 13-23 |
123 | ″ | schema:productId | N43aed1876a9047428d03c398d391d064 |
124 | ″ | ″ | Nedf39fd58af44e9faaa1a5086bf79e53 |
125 | ″ | schema:publisher | N96ca0a066cb44feaa66a56f10ef27347 |
126 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1090680142 |
127 | ″ | ″ | https://doi.org/10.1007/978-3-319-43383-7_2 |
128 | ″ | schema:sdDatePublished | 2022-05-20T07:45 |
129 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
130 | ″ | schema:sdPublisher | Naaf0c8b93fd846219b937893b8dd7595 |
131 | ″ | schema:url | https://doi.org/10.1007/978-3-319-43383-7_2 |
132 | ″ | sgo:license | sg:explorer/license/ |
133 | ″ | sgo:sdDataset | chapters |
134 | ″ | rdf:type | schema:Chapter |
135 | N01e6a245106a40bdb2dd101ca33f37ee | rdf:first | sg:person.01117454426.66 |
136 | ″ | rdf:rest | rdf:nil |
137 | N1143df90947b412d9806a50fe22055f8 | schema:familyName | Musumeci |
138 | ″ | schema:givenName | Francesco |
139 | ″ | rdf:type | schema:Person |
140 | N134d913130ec41fd985112dee1313180 | rdf:first | sg:person.01246247247.72 |
141 | ″ | rdf:rest | Ne996445b6b4042efb99115cfad9d5649 |
142 | N199017a168664d8aa7b7a16f622e909e | schema:familyName | Krabatsch |
143 | ″ | schema:givenName | Thomas |
144 | ″ | rdf:type | schema:Person |
145 | N26b523d21f4547e68ba20ab58ec40b03 | rdf:first | sg:person.01051341226.47 |
146 | ″ | rdf:rest | N134d913130ec41fd985112dee1313180 |
147 | N2db848adae90449594ad99a4ca5a765a | schema:familyName | Montalto |
148 | ″ | schema:givenName | Andrea |
149 | ″ | rdf:type | schema:Person |
150 | N39a8cea3c5024bfeab4334f28d51da88 | schema:familyName | Slaughter |
151 | ″ | schema:givenName | Mark S. |
152 | ″ | rdf:type | schema:Person |
153 | N43aed1876a9047428d03c398d391d064 | schema:name | dimensions_id |
154 | ″ | schema:value | pub.1090680142 |
155 | ″ | rdf:type | schema:PropertyValue |
156 | N44176f74f30b4ebe9f35db0fb18c0049 | rdf:first | N199017a168664d8aa7b7a16f622e909e |
157 | ″ | rdf:rest | N573b2aa3532248ea8c135e3e517e7346 |
158 | N573b2aa3532248ea8c135e3e517e7346 | rdf:first | N39a8cea3c5024bfeab4334f28d51da88 |
159 | ″ | rdf:rest | rdf:nil |
160 | N627151392ef84b18b1146c33307f050c | rdf:first | N7e3ccae4fe014c9e847f1bdcc2328d14 |
161 | ″ | rdf:rest | N9af288c25e324e8096ed259f97e0e588 |
162 | N7adb950440e142508c9f64529e821022 | rdf:first | sg:person.016116527146.47 |
163 | ″ | rdf:rest | N26b523d21f4547e68ba20ab58ec40b03 |
164 | N7e3ccae4fe014c9e847f1bdcc2328d14 | schema:familyName | Loforte |
165 | ″ | schema:givenName | Antonio |
166 | ″ | rdf:type | schema:Person |
167 | N807fd67e22be4f43af92d5824b1858e3 | rdf:first | N2db848adae90449594ad99a4ca5a765a |
168 | ″ | rdf:rest | N627151392ef84b18b1146c33307f050c |
169 | N96ca0a066cb44feaa66a56f10ef27347 | schema:name | Springer Nature |
170 | ″ | rdf:type | schema:Organisation |
171 | N9af288c25e324e8096ed259f97e0e588 | rdf:first | N1143df90947b412d9806a50fe22055f8 |
172 | ″ | rdf:rest | N44176f74f30b4ebe9f35db0fb18c0049 |
173 | Na2778b09f82a45268e1a06284a8066d7 | schema:isbn | 978-3-319-43381-3 |
174 | ″ | ″ | 978-3-319-43383-7 |
175 | ″ | schema:name | Mechanical Circulatory Support in End-Stage Heart Failure |
176 | ″ | rdf:type | schema:Book |
177 | Naaf0c8b93fd846219b937893b8dd7595 | schema:name | Springer Nature - SN SciGraph project |
178 | ″ | rdf:type | schema:Organization |
179 | Ne996445b6b4042efb99115cfad9d5649 | rdf:first | sg:person.0735112626.95 |
180 | ″ | rdf:rest | N01e6a245106a40bdb2dd101ca33f37ee |
181 | Nedf39fd58af44e9faaa1a5086bf79e53 | schema:name | doi |
182 | ″ | schema:value | 10.1007/978-3-319-43383-7_2 |
183 | ″ | rdf:type | schema:PropertyValue |
184 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
185 | ″ | schema:name | Medical and Health Sciences |
186 | ″ | rdf:type | schema:DefinedTerm |
187 | anzsrc-for:1102 | schema:inDefinedTermSet | anzsrc-for: |
188 | ″ | schema:name | Cardiorespiratory Medicine and Haematology |
189 | ″ | rdf:type | schema:DefinedTerm |
190 | anzsrc-for:1103 | schema:inDefinedTermSet | anzsrc-for: |
191 | ″ | schema:name | Clinical Sciences |
192 | ″ | rdf:type | schema:DefinedTerm |
193 | sg:person.01051341226.47 | schema:affiliation | grid-institutes:grid.416308.8 |
194 | ″ | schema:familyName | Montalto |
195 | ″ | schema:givenName | A. |
196 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051341226.47 |
197 | ″ | rdf:type | schema:Person |
198 | sg:person.01117454426.66 | schema:affiliation | grid-institutes:grid.416308.8 |
199 | ″ | schema:familyName | Musumeci |
200 | ″ | schema:givenName | Francesco |
201 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01117454426.66 |
202 | ″ | rdf:type | schema:Person |
203 | sg:person.01246247247.72 | schema:affiliation | grid-institutes:None |
204 | ″ | schema:familyName | Amarelli |
205 | ″ | schema:givenName | C. |
206 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01246247247.72 |
207 | ″ | rdf:type | schema:Person |
208 | sg:person.016116527146.47 | schema:affiliation | grid-institutes:grid.416308.8 |
209 | ″ | schema:familyName | Piazza |
210 | ″ | schema:givenName | Vito |
211 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016116527146.47 |
212 | ″ | rdf:type | schema:Person |
213 | sg:person.0735112626.95 | schema:affiliation | grid-institutes:grid.412311.4 |
214 | ″ | schema:familyName | Loforte |
215 | ″ | schema:givenName | A. |
216 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0735112626.95 |
217 | ″ | rdf:type | schema:Person |
218 | grid-institutes:None | schema:alternateName | Department of Cardiovascular Surgery and Transplants Monaldi, Azienda dei Colli, Neaples, Italy |
219 | ″ | schema:name | Department of Cardiovascular Surgery and Transplants Monaldi, Azienda dei Colli, Neaples, Italy |
220 | ″ | rdf:type | schema:Organization |
221 | grid-institutes:grid.412311.4 | schema:alternateName | Department of Cardiovascular Surgery and Transplantation, S. Orsola-Malpighi Hospital, Bologna University, Bologna, Italy |
222 | ″ | schema:name | Department of Cardiovascular Surgery and Transplantation, S. Orsola-Malpighi Hospital, Bologna University, Bologna, Italy |
223 | ″ | rdf:type | schema:Organization |
224 | grid-institutes:grid.416308.8 | schema:alternateName | Department of Cardiac Surgery and Heart Transplantation, San Camillo Hospital, Rome, Italy |
225 | ″ | ″ | Director of Cardiovascular Medicine, Director of Cardiac Surgery and Transplantation, San Camillo-Forlanini Hospital, Rome, Italy |
226 | ″ | ″ | Division of Cardiology, Department of Cardiac Surgery and Heart Transplantation, San Camillo Hospital, Circonvallazione Gianicolense 87, 00152, Rome, Italy |
227 | ″ | schema:name | Department of Cardiac Surgery and Heart Transplantation, San Camillo Hospital, Rome, Italy |
228 | ″ | ″ | Director of Cardiovascular Medicine, Director of Cardiac Surgery and Transplantation, San Camillo-Forlanini Hospital, Rome, Italy |
229 | ″ | ″ | Division of Cardiology, Department of Cardiac Surgery and Heart Transplantation, San Camillo Hospital, Circonvallazione Gianicolense 87, 00152, Rome, Italy |
230 | ″ | rdf:type | schema:Organization |